IMPACTIntegrative Chinese-Western Medicine Management for COPD with Comorbidities
This observational study aims to monitor the annual rate of COPD exacerbations and the incidence of related comorbidities, such as hypertension, coronary artery disease, arrhythmia, heart failure, and diabetes, in individuals managed with a combination of Chinese and Western medicine.
Data Collection
Collected from today forward - ProspectiveChronic Disease+5
+ Lung Diseases
+ Lung Diseases, Obstructive
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: February 26, 2026
Actual date on which the first participant was enrolled.COPD, or Chronic Obstructive Pulmonary Disease, is a common, long-term respiratory condition that often comes with other health issues. These additional conditions can worsen COPD symptoms, cause sudden flare-ups, lead to hospital stays, and contribute to the disease's progression over time. This study, called the IMPACT COPD Cohort in China, aims to create a real-world foundation for managing COPD and its related health issues using a combined approach of Chinese and Western medicine. The study focuses on individuals at high risk and those already diagnosed with related conditions, with the goal of improving long-term care, addressing current challenges, and meeting unmet needs for COPD management. Participants in this observational study will undergo regular clinical evaluations, including symptom assessments, questionnaires, lung function tests, imaging, and biomarker analysis. They will also use wearable devices to continuously monitor heart rate, blood pressure, activity levels, sleep patterns, and other physiological and behavioral measures. Additionally, the study will employ digital Traditional Chinese Medicine techniques, such as tongue, pulse, and facial diagnostics. The primary outcomes measured are the annual rate of COPD flare-ups and the occurrence of related conditions like high blood pressure, heart diseases, diabetes, among others.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.10000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 40 to 80 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 4 locations
Hebi Coal Industry Group General Hospital
Hebi, ChinaOpen Hebi Coal Industry Group General Hospital in Google MapsTongliao Second People's Hospital
Tongliao, ChinaMianyang Third People's Hospital
Mianyang, ChinaThe First Affiliated Hospital of Shihezi University
Shihezi, China